Dalian BIO-CHEM Company Limited

SSE:603360.SS

28.36 (CNY) • At close April 30, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42014 Q22014 Q1
Revenue 448.322416.071309.729244.664338.254214.775277.85315.179257.857252.658343.559366.375294.068314.311216.757256.796218.397182.684169.153198.022199.683270.307251.7212.802137.087125.308150.806126.245125.812113.966105.38395.26695.74995.457106.69104.38582.90270.55491.25691.256
Cost of Revenue 307.159249.147165.147134.022182.958114.794128.258142.448125.734120.68160.139188.493119.268149.235127.369140.582119.283107.75576.75877.6773.6296.36782.61887.74674.02455.56972.69371.88573.09652.17652.32646.49249.1174551.354.53543.09235.63655.09355.093
Gross Profit 141.163166.924144.582110.642155.29699.981149.591172.731132.123131.978183.42177.882174.8165.07789.388116.21499.11474.92992.395120.352126.063173.94169.082125.05663.06369.73978.11354.35952.71661.79153.05748.77446.63250.45755.38949.8539.81134.91836.16236.162
Gross Profit Ratio 0.3150.4010.4670.4520.4590.4660.5380.5480.5120.5220.5340.4860.5940.5250.4120.4530.4540.410.5460.6080.6310.6430.6720.5880.460.5570.5180.4310.4190.5420.5030.5120.4870.5290.5190.4780.480.4950.3960.396
Reseach & Development Expenses 18.69813.26115.03511.01510.3459.56311.35510.1937.8685.62910.36516.2514.89115.09210.538.2666.1439.1318.8239.031.58511.3639.16.0071.6688.887.7341.5541.74915.16603.107013.99302.86804.3642.3872.387
General & Administrative Expenses 38.325-41.85747.3518.22428.067-38.0954.373.9629.795-41.52270.412-3.92226.378-11.91943.8684.5923.98-30.76919.52528.77818.24319.08215.625-3.74617.023-21.31610.909-6.3911.943-28.04115.338-6.19111.542-28.03516.353-6.38610.352-26.0547.2687.268
Selling & Marketing Expenses 12.5-0.954-15.5053.5333.1094.5794.1332.4122.783.0913.324-11.88516.9342.6623.9962.8692.543-17.126.34513.8787.27314.6457.4058.7264.248.5128.6755.6193.2817.1973.7956.1044.2367.8292.7077.0551.9576.485.1945.194
SG&A 50.825-42.81131.86511.75631.176-33.5158.5046.37232.575-38.43173.736-15.80643.312-9.25647.8647.45926.523-47.88825.8742.65625.51633.72623.034.9821.263-12.80419.584-0.77115.224-20.84419.134-0.08815.778-20.20619.060.66912.309-19.57413.47213.472
Other Expenses 1.86868.8790-0.0650.018-0.1650.022-02.84886.094-24.17430.8160.985-11.5050.4990.324-0.001-1.2762.012-0.461-0.024-1.9581.7740.076-0.012-0.5050.0020.0020.005-6.4632.1622.8511.3712.8821.0862.2180.5811.99800
Operating Expenses 71.39139.3346.945.88542.92141.08645.4247.18643.29153.29359.92731.2659.18845.15640.88333.28434.01811.04136.99765.44629.22572.41935.92332.68824.11727.34828.42417.5417.41118.28221.38120.22817.61928.26420.38618.17913.93124.06213.34113.341
Operating Income 69.772127.59497.68374.388112.46158.576107.359136.49883.4960.178133.791150.498117.161113.2644.59883.80961.05555.43754.10651.37899.79699.906135.08994.24838.30142.93753.19342.9233.06936.10530.17728.82931.35125.83533.52227.14321.8367.57620.74420.744
Operating Income Ratio 0.1560.3070.3150.3040.3320.2730.3860.4330.3240.2380.3890.4110.3980.360.2060.3260.280.3030.320.2590.50.370.5370.4430.2790.3430.3530.340.2630.3170.2860.3030.3270.2710.3140.260.2630.1070.2270.227
Total Other Income Expenses Net -0.031-0.0522.248-0.0656.38-1.4830.0229.149-0.001-2.5496.7279.6452.028-11.5050.6850.139-2.1747.2432.012-0.4622.9337.5623.7043.724-0.657-0.5053.5055.328-2.231-0.1552.1532.8483.7092.7951.0860.259-3.4621.998-0.931-0.931
Income Before Tax 69.74127.54299.93174.323112.47858.411107.381136.49783.48859.942133.824150.532117.135101.75645.28383.94761.05453.46356.11850.91799.77197.948136.86394.32438.28942.43153.19542.92233.07429.65532.3331.67832.72228.6334.60829.3622.4189.57419.81319.813
Income Before Tax Ratio 0.1560.3070.3230.3040.3330.2720.3860.4330.3240.2370.390.4110.3980.3240.2090.3270.280.2930.3320.2570.50.3620.5440.4430.2790.3390.3530.340.2630.260.3070.3330.3420.30.3240.2810.270.1360.2170.217
Income Tax Expense 9.74222.9410.268.08414.16512.97314.30319.29410.833-6.61125.39921.4118.66911.3978.26612.6629.22210.5175.2712.9169.81125.31815.24913.7016.3555.8267.77.2715.7611.1015.4684.6355.2983.0355.584.563.8960.4592.672.67
Net Income 50.16291.03489.67166.23898.31345.43893.079117.20372.65566.553108.426129.12198.46690.35937.01771.28551.83142.94550.84838.00189.9672.63121.61480.62331.93436.60645.49535.77327.31318.79726.86227.12227.48525.67329.08824.90318.6099.18117.14317.143
Net Income Ratio 0.1120.2190.290.2710.2910.2120.3350.3720.2820.2630.3160.3520.3350.2870.1710.2780.2370.2350.3010.1920.4510.2690.4830.3790.2330.2920.3020.2830.2170.1650.2550.2850.2870.2690.2730.2390.2240.130.1880.188
EPS 0.10.180.190.140.270.40.260.330.210.20.430.510.390.280.140.280.140.160.140.20.240.280.340.310.0870.140.120.130.0770.0710.0710.110.0770.130.110.130.0690.0480.0620.062
EPS Diluted 0.10.180.190.140.270.40.260.330.210.20.430.510.390.270.140.280.140.160.140.20.240.280.340.310.0870.140.120.130.0770.0710.0710.110.0770.130.110.130.0690.0480.0620.062
EBITDA 76.445129.583100.58976.361131.15774.653124.431152.674101.87179.268152.887168.051134.653121.65462.7597.40672.91662.58571.88662.538111.369107.328139.104103.35444.98148.52350.45340.6935.30538.24132.40138.73529.01333.51241.80134.89431.3914.97821.97721.977
EBITDA Ratio 0.1710.3110.3250.3120.3880.3480.4480.4840.3950.3140.4450.4590.4580.3870.2890.3790.3340.3430.4250.3160.5580.3970.5530.4860.3280.3870.3350.3220.2810.3360.3070.4070.3030.3510.3920.3340.3790.2120.2410.241